About this trial
To confirm feasibility and accessibility of the CCPC Platform (Oxymotion, Bridge Health Solutions medication adherence software, CloudDX home kit) in two different environments - 1) hospital (Acute Care for Elderly Unit) and 2) at-home .
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Inpatients on the Acute care of the Elderly ward.
Disqualifiers
Lack of capacity to consent to the study including moderate-severe dementia or delirium
Unable to use (or does not have a caregiver who can help put on) study monitoring device at home
Unable to complete (or does not have a caregiver who can help complete) study questionnaires by electronic (mobile, tablet, or computer), paper, nor phone
Patient with known allergic reactions to any part material of the device
Trial population
The Acute Care for Elderly Unit at SPH for 40 inpatients over the age of 65.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Collect patient and clinicians' feedback about the CCPC Platform
This will be completed via an assessment of the quantitative data on how long and how often patients use this monitoring and what were the reasons that patients took the monitors on and off.
Collect patient and clinicians' feedback about the CCPC Platform
This will be completed via an assessment of the Usability Questionnaire.
Collect patient and clinicians' feedback about the CCPC Platform
This will be completed by an evaluation for potential harm, e.g. anxiety questionnaire and any patient-reported adverse events.
Confirm the technical goals of the CCPC platform are met.
This will be completed by ensuring clinician workflow is met, via feedback sessions (e.g. conversations, questionnaires).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Medtronic - MITG
Lead sponsor
Excelar
Collaborator
Cloud DX Inc.
Collaborator
Bridge Health Solutions
Collaborator
Providence Healthcare
Collaborator